Current Situation
Transfer of recipe and process data from R&D labs to manufacturing facilities is accomplished using paper or pdf (“paper on glass”).
Goals and Objectives
Digital tech transfer eliminates potential mistakes, reduces need for experiments, and reduces time to manufacture for new products or existing products moving to new facilities.
Technology Deployed
Cloud, analytics, IoT, and security
Use Case Summary
Digital technology transfer for biopharma manufacturing will help life science companies bring new drugs to market more quickly and with higher quality, by eliminating paper processes associated with replicating recipe, equipment, materials, and process data in digital form. This will reduce the need for onsite experiments and reentry of process parameters for global biopharma manufacturing.